Taking a Sexual History Is an Essential Part of Good Health Care
Sex is a vital part of human life—and clinicians should be asking about it.
This Week in HIV Research: Many Sizes Fit Many People
Oct. 15, 2020: Adherence barriers among Latinx MSM; Atlanta's Ending the HIV Epidemic priorities; Ryan White HIV service coordination; PrEP, white coat dosing, and drug resistance.
Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
HIV Care and Coronavirus (COVID-19): The Latest Info and Guidance
Multiple U.S. health agencies have released HIV-specific information, and research on HIV and the novel coronavirus is trickling in. Here's what health care providers need to know.
Our Newest Posts
This Week in HIV Research: Revisiting Our Needs
Oct. 8, 2020: HPV-related cancer risk among women living with HIV; the interplay between HIV, HBV, and liver disease; Framingham vs. other tools to gauge statin value; integrase inhibitors, weight gain, and menopause.
Smoking Rates Are Higher in the LGBTQ Community; Can More Inclusive Data Help?
Scout, Ph.D., the head of the National LGBT Cancer Network, lays out the current state of the interplay between nicotine, cancer, HIV, and people who are LGBTQ.
This Week in HIV Research: Incidence and Clinical Care Trends Among MSM
Oct. 1, 2020: HIV surveillance trends among U.S. MSM; health insurance and viral suppression; PrEP prescribing among motivated clinicians; PrEP sharing between MSM.
How to De-Escalate Conflict in HIV Care and Community Health
For some clients, escalation is how they communicate that they feel unsafe or feel that their needs are not being taken seriously.
Hepatitis C Treatment Barriers Persist Through the Cure Era, Especially in U.S.
For the most vulnerable populations disproportionately impacted by HCV in the U.S.—i.e., incarcerated people and people who inject drugs—treatment remains dangerously elusive, experts say.
Robert Redfield’s Epic COVID Failure Is Not a Surprise to Many HIV and Public Health Experts
They say that the longtime HIV researcher already had a sketchy record that made him the perfect Trump flunky.
Refer your clients and patients to TheBody, TheBodyPro's sibling site for people living with or affected by HIV. TheBody delivers vital information, news, support, and personal perspectives on HIV and related issues.
